Mark Cabling - Publications

View Profile »

Advancing the Development and Use of Diagnostic Target Product Profiles for Cancer

2024
The burden of respiratory syncytial virus in adults in the UK

2024
Culture of Presenteeism: Emergent Perspectives from an NHS-workforce Convenience Sample

2024
Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Australia

2024
Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in the United Kingdom

2024
Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Italy

2024
Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Canada

2024
Faecal microbiota transplantation for recurrent C. difficile, infections: Challenges and improvement opportunities for clinical practice and healthcare systems

2024
Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective

2024
Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Italy

2024
Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Canada

2024
Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Australia

2024
Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in the United Kingdom

2024
Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in France

2024
Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

2023
Machine Learning and gene editing at the helm of a societal evolution

2023
The societal and indirect economic burden of seasonal influenza in the United Kingdom

2023
Study on a Future-Proofing Analysis of the 2017 EU AMR Action Plan

2023
Faecal Microbiota Transplantation for Recurrent C. Difficile Infections: Challenges and Improvement Opportunities for Clinical Practice and Healthcare Systems

2022
Improving Care for Patients with Clostridioides Difficile Infection: A Clinical Practice and Healthcare Systems Perspective

2022

Mark Cabling - Publications

Advancing the Development and Use of Diagnostic Target Product Profiles for Cancer

The burden of respiratory syncytial virus in adults in the UK

Culture of Presenteeism: Emergent Perspectives from an NHS-workforce Convenience Sample

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Australia

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in the United Kingdom

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Italy

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Canada

Faecal microbiota transplantation for recurrent C. difficile, infections: Challenges and improvement opportunities for clinical practice and healthcare systems

Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Italy

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Canada

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Australia

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in the United Kingdom

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in France

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

Machine Learning and gene editing at the helm of a societal evolution

The societal and indirect economic burden of seasonal influenza in the United Kingdom

Study on a Future-Proofing Analysis of the 2017 EU AMR Action Plan

Faecal Microbiota Transplantation for Recurrent C. Difficile Infections: Challenges and Improvement Opportunities for Clinical Practice and Healthcare Systems

Improving Care for Patients with Clostridioides Difficile Infection: A Clinical Practice and Healthcare Systems Perspective

RAND Headquarters

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Mark Cabling - Publications

Advancing the Development and Use of Diagnostic Target Product Profiles for Cancer

The burden of respiratory syncytial virus in adults in the UK

Culture of Presenteeism: Emergent Perspectives from an NHS-workforce Convenience Sample

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Australia

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in the United Kingdom

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Italy

Faecal microbiota transplantation (FMT): Challenges and opportunities for the treatment and prevention of recurrent C. difficile infection (rCDI) in Canada

Faecal microbiota transplantation for recurrent C. difficile, infections: Challenges and improvement opportunities for clinical practice and healthcare systems

Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Italy

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Canada

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in Australia

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in the United Kingdom

Improving care for patients with Clostridioides difficile infection (CDI): Challenges and opportunities for diagnosis, treatment and management in France

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

Machine Learning and gene editing at the helm of a societal evolution

The societal and indirect economic burden of seasonal influenza in the United Kingdom

Study on a Future-Proofing Analysis of the 2017 EU AMR Action Plan

Faecal Microbiota Transplantation for Recurrent C. Difficile Infections: Challenges and Improvement Opportunities for Clinical Practice and Healthcare Systems

Improving Care for Patients with Clostridioides Difficile Infection: A Clinical Practice and Healthcare Systems Perspective